L'azione della DSC nel campo della salute

© dsc

L’azione della DSC nel campo della salute mette in primo piano tre aspetti: il rafforzamento dei sistemi sanitari, la lotta contro le malattie trasmissibili e non trasmissibili e il miglioramento della salute sessuale, riproduttiva, materna, neonatale e infantile. La DSC interviene in Paesi a reddito basso e medio, in contesti stabili o fragili, e in economie in transizione.

Rafforzamento dei sistemi sanitari

Le grandi sfide sono soprattutto la mancanza di personale sanitario, di finanziamenti, di buongoverno e capacità di gestione, la scarsa disponibilità e qualità di infrastruttura, tecnologia e prodotti medici adeguati.

Salute sessuale e riproduttiva

Migliorare la salute delle madri, dei neonati e dei bambini e promuovere una vita sessuale e riproduttiva soddisfacente e senza rischi.

Malattie

Mettere in atto strategie per la promozione di uno stile di vita sano, la prevenzione, la diagnosi e il trattamento delle malattie non trasmissibili; sostenere la prevenzione, il trattamento e la ricerca di nuovi farmaci e strumenti diagnostici contro le malattie tropicali trascurate, la malaria, la tubercolosi, l’AIDS, la diarrea e i disturbi respiratori acuti.

Documenti

Progetti attuali

Oggetto 37 – 48 di 135

African Risk Capacity (ARC)

10.12.2019 - 31.12.2022

The African Risk Capacity is a disaster risk management pool and early response mechanism established by the African Union member states against natural disasters like drought, flood, and tropical cyclones, and the outbreak of highly contagious diseases. Its drought insurance and the new insurance products for flood and tropical cyclones enhance the safety nets of smallholder households and thus contributes to food security in Africa.


ESTHER Switzerland (Ensemble pour une Solidarité Thérapeutique Hospitalière En Réseau)

01.12.2019 - 30.11.2024

ESTHER Switzerland provides a mechanism for systematic mobilisation and use of Swiss healthcare expertise to strengthen human resource capacities for health and consequently the quality of service delivery in low and middle-income countries. ESTHER promotes institutional partnerships between Swiss hospitals or research entities with institutions of the same kind in partner countries so as to address priority needs in terms of service delivery.


Urban Governance for Health and Wellbeing

01.12.2019 - 30.11.2028

Rapid and unplanned urbanization results in poor health. The COVID-19 crisis has put city governments and urban communities at the frontline of the response. Enhancing urban governance for health and building resilient cities contribute to addressing these challenges. Switzerland, with its strong focus on civic engagement and its experience in participative urban development, plays a key role in catalysing action to create healthier urban environments in low- and middle-income countries.


Addressing Determinants of Health for Advancing Equity

01.12.2019 - 30.11.2024

Despite overall health gains, the distribution of health is vastly unequal. Investment in determinants of health such as education or water is considered as an effective means of preventing disease and contributing to health equity. Building on Swiss expertise in addressing factors such as health literacy, the program will elaborate normative guidance, produce evidence, advocate for action, and build capacity to advance health equity and leave no one behind in selected low- and middle-income countries.


Dynamic electronic decision trees for managing childhood illness (DYNAMIC)

15.11.2019 - 31.12.2022

Every year, more than five million children die before the age of five due to preventable or treatable causes, most of them in developing countries. New technologies combined with rapid tests can improve diagnosis and management of sick children and reduce health costs. This collaborative research project makes use of Switzerland’s knowledge in digital technologies to improve the health of children and reduce unnecessary antibiotic prescriptions in low resource settings.


Improving Access to Essential Medicines and Basic Technologies for Non-communicable Diseases

01.11.2019 - 31.12.2031

Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage (broader access engagement as a country with a big pharma sector), the program addresses all components of the comprehensive framework for access to drugs, ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy, information and innovation.


“Mental Health for Universal Health Coverage” (MH4UHC)

01.11.2019 - 31.10.2024

In low resource settings, less than 20% of people with mental disorders have access to mental health services. Building on best practices and experience from Swiss supported programs at country level, the Special Initiative for Mental Health aims to increase access to care for people with mental disorders in low- and middle-income countries. Priority areas are advocacy for investments in mental health, evidence-based policy formulation, and integration of mental health services at primary healthcare level.


Menstrual Health Management (MHM)

15.09.2019 - 31.12.2021

Despite being the majority, young people have the worst HIV outcomes. Evidence-based, demographic and context-adapted responses are essential if ending AIDS by 2030 is to be attained. Proposed is a population level study to determine the impact of a comprehensive community based package of HIV services with a nested sub-study on Menstrual Health Management (MHM). Even though it is often neglected, MHM is crucial for women’s social inclusion, health and gender equality


WHO’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)

01.08.2019 - 31.07.2024

The Expanded Special Project for Elimination of Neglected Tropical Diseases strives to eliminate the five most prevalent neglected tropical diseases in Africa, by providing preventive treatment against e.g. river blindness for free to 600 million people. This continental initiative is carried out by a public-private partnership including pharmaceutical companies. The Swiss contribution makes it possible to accelerate the elimination of the diseases by expanding to more countries and people.


Contribution à la stabilité et à la reconstruction en République Centrafricaine (RCA)

01.08.2019 - 31.12.2023

La RCA se caractérise par la fragilité de ses institutions et par la récurrence de ses crises politiques et humanitaires. La gouvernance et la santé constituent deux secteurs pour lesquels la Suisse dispose d’une valeur ajoutée et pour lesquels elle a décidé de s’engager en RCA par des actions complémentaires d’aide d’urgence et de développement à long terme. Cet engagement est cohérent avec ceux déjà existants dans les pays prioritaires de la coopération internationale en Afrique subsaharienne ; il participera à la stabilisation de la région, consolidera la paix et contribuera à des services de santé accessibles et de qualité en RCA.


Accountability in Health & Agriculture

01.07.2019 - 30.06.2023

While governments have translated regional policies on Food Security and Sexual and Reproductive Health and Rights (SRHR) into national policies, these are poorly implemented and the public lacks capacities to act effectively upon them. The project will improve the accountability and gender responsiveness of public resource management and complement the ongoing Swiss funded projects in ensuring that policy/advocacy work developed at national, regional and global levels is disseminated and implemented by relevant SADC and governmental institutions.


Global Malaria Technical & Training Support Package (GlobMal)

01.07.2019 - 30.06.2023

The worldwide reduction in malaria-related death in the last two decades is a major global public health success. Despite the 6 million lives saved from malaria, still more than 400’000 people die every year. The project aims to shape effective global and national malaria control and elimination strategies, by providing the necessary scientific evidence and strengthening capacities of malaria-affected countries. Swiss research and private sector contribute to the design and implementation of these global and national malaria strategies.

Oggetto 37 – 48 di 135